US Federal Senate Bill SB1460

US Federal 2025-2026 Regular Session

• Introduced: 4/10/25
• Refer: 4/10/25

Caption

Preserving Patient Access to Accountable Care Act

Summary

SB 1460, titled the Preserving Patient Access to Accountable Care Act, would extend Medicare incentive payments for clinicians and other participants in eligible alternative payment models (APMs). The bill amends section 1833(z) of the Social Security Act to push the current incentive-payment schedule out by one year, changing references from 2026 to 2027 and from 2027 to 2028, and it adds a 3.53 percent incentive rate for 2027. It also makes conforming changes to related Medicare payment provisions in section 1848(q). In practical terms, the bill would continue the existing bonus structure for providers who participate in qualifying accountable care and other alternative payment arrangements under Medicare. These incentives are intended to encourage value-based care, coordination, and cost control by rewarding providers for moving away from traditional fee-for-service reimbursement. The legislation does not create a new program; it extends and updates the timing of an existing one. The bill’s impact on state laws is indirect, because it amends federal Medicare law rather than state statutes. Its primary effect would be on Medicare payment policy, affecting physicians, accountable care organizations, and other providers participating in eligible APMs nationwide. By preserving incentive payments for an additional year, the bill could influence provider participation decisions and Medicare reimbursement expectations. The available context shows no committee debate or recorded votes, so there is no documented partisan split or formal opposition in the materials provided. The bill was introduced by a bipartisan group of senators, which suggests generally favorable or at least collaborative support for extending the incentive structure. The title and sponsor mix indicate a shared interest in maintaining patient access and supporting accountable care models. The main point of potential contention is fiscal and policy timing: extending incentive payments may be viewed as supporting provider participation and care transformation, but it also continues federal spending and may raise questions about whether the current APM incentive framework should be extended, modified, or allowed to expire. Any disagreement would likely center on Medicare payment policy, budget impact, and whether the extension sufficiently advances value-based care goals.

Impact

This bill would amend federal Medicare law, specifically sections 1833(z) and 1848(q) of the Social Security Act, to extend incentive payments for participation in eligible alternative payment models through 2027 and adjust related payment references into 2028. It would affect Medicare-participating physicians, accountable care organizations, and other providers in value-based payment arrangements, but it would not directly change state statutes or state-administered programs.

Sentiment

The bill appears to have generally positive, bipartisan support based on its introduction by senators from both parties and the absence of recorded opposition, committee debate, or votes in the provided materials. The framing of the measure as preserving patient access and accountable care suggests a favorable policy posture toward continuing Medicare’s value-based payment incentives.

Contention

No specific objections are documented in the provided context, but the likely areas of contention are policy and budget related: whether extending Medicare incentive payments is the best use of federal funds, whether the current alternative payment model framework should be prolonged without broader reform, and how the extension might affect Medicare spending and provider behavior. Any disagreement would likely come from lawmakers focused on fiscal restraint or on redesigning Medicare payment incentives rather than extending them.